Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide)

Brock N, Hohorst H-J: The activation of cyclophosphamide in vivo and in vitro. Arzneimittel-Forschung 13:1030–1040, 1963

Sladek NE: Metabolism of cyclophosphamide by rat hepatic microsomes. Cancer Res 31:901–908, 1971

Cohen JL, Jao JY: Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. J Pharmacol Exp Ther 174(2):206–210, 1970

Brock N, Hohorst H-J: The problem of specificity and selectivity of alkylating cytostatics. Studies on N-2-chloroethylamine-oxazaphosphorines. Z Krebsforsch 88:185–215, 1977

Cox PJ, Phillips BJ, Thomas P: The enzymatic basis of the selective action of cyclophosphamide. Cancer Res 35:3755–3761, 1975

Fenselau C, Kan M-NN, Rao SS, Myles A, Friedman OM, Colvin M: Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans. Cancer Res 37:3738–3741, 1977

Domeyer BE, Sladek NE: Kinetics of cyclophosphamide biotransformation in vivo. Cancer Res 40:174–180, 1980

Struck RF, Kirk MC, Witt MH, Laster WR: Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite. Biomed Mass Spectrometry 2:46–52, 1975

Friedman OM, Wodinsky I, Myles A: Cyclophosphamide-related phosphoramide mustards — recent advances and historical perspective. Cancer Treat Rep 60:337–346, 1976

Pohl J: ASTA Z 7557, Summary of Investigators. Asta-Werke, DeGussa Pharma Gruppe, D-4800 Bielefeld, F.R.D., 1983

Lieber MM, Ames MM, Powis G, Kovach JS: Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay. Life Sci 28(3):287–293, 1981

Alberts DS, Chen H-SG, Salmon SE: in vitro drug assay: pharmacologic considerations. In SE Salmon (ed.): Cloning of Human Tumor Stem Cells. A. Liss & Co., New York, 1980, pp 197–207

Alberts DS, Salmon SE, Chen H-SG, Moon TE, Young L, Surwit EA: Pharmacologic studies of anticancer drugs using the human tumor stem cell assay. Cancer Chemother Pharmacol 6:253–264, 1981

Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197:461–463, 1977

Salmon SE, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298:1321–1327, 1978

Arnold H, Bouvseaux F, Brock N: Neuartige Krebs-chemotherapeutica aus der gruppe der zyklischen N-losi-phosphamidester. Naturwissenschaften 45:64–66, 1958

Dolfini E, Martini A, Dorelli MG: Method for tissue culture evaluation of the cytotoxic activity of drugs active through the formation of metabolites. Eur J Cancer 9:375–378, 1973

Meltz M, Winters D: Utilization of metabolic activation for in vitro screening of potential antineoplastic agents. Cancer Treat Rep 63:1795–1801, 1979

Salmon SE: Applications of the human tumor stem cell assay to new drug evaluation and screening. In SE Salmon (ed.): Cloning of Human Tumor Stem Cells. A. Liss & Co., New York, 1980, pp 291–314

Shoemaker RH, Wolpert-Defilippes MK, Makuch RW, Venditti JM: The use of the human tumor clonogenic assay for new drug screening (Abstract). Proc Am Assoc Cancer Res 24:311, 1983

Salmon SE, Meyskens FL Jr, Alberts DS, Soehnlen B, Young L: New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor clonogenic assay. Cancer Treat Rep 65:1–12, 1981

Von Hoff DD, Coltman CA, Forseth B: Activity of mitoxantrone in a human tumor cloning system. Cancer Res 41:1853–1855, 1981

Alberts DS, Chen H-SG, Salmon SE, Surwit EA, Young L, Moon TE, Meyskens FL Jr: Chemotherapy of ovarian cancer directed by the human tumor stem cell assay. Cancer Chemother Pharmacol 6:279–285, 1981

Alberts DS, Chen H-SG, Soehnlen B, Salmon SE, Surwit EA, Young L: In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 2:340–342, 1980

Salmon SE, Alberts DS, Meyskens FL Jr, Durie BGM, Jones SE, Soehnlen B, Young L, Chen H-SG, Moon TE: Clinical correlations of in vitro drug sensitivity. In SE Salmon (ed): Cloning of Human Tumor Stem Cells. A. Liss & Co., New York, 1980, pp 223–245

Salmon SE, Von Hoff DD: In vitro evaluation of anticancer drugs with the human tumor stem cell assay. Seminars Oncol 8(4):377–385, 1981

Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF: Prospective clinical trial of a human tumor cloning system. Cancer Res 43:1926–1931, 1983

Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen B, Alberts DS, Schmidt HJ: Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 38:3438–3443, 1978

Pavelic ZP, Slocum HK, Rustum YM, Creavin PJ, Karakousis C, Takita H: Colony growth in soft agar of human myeloma, sarcoma and lung carcinoma ells dis-aggregated by mechanical and enzymatic methods. Cancer Res 40:2160–2164, 1980

Hamburger AW, White CP, Tencer K: Effect of enzymatic disaggregation on proliferation of human tumor cells in soft agar. J Natl Cancer Inst 68(6):945–948, 1981

Salmon SE, Liu R, Hayes C, Persaud J, Roberts R: Usefulness of abrin as a positive control for the human tumor clonogenic assay. Invest N Drugs 1:277–281, 1983

Kressner B, Morton RRA, Martens AE, Salmon SE, Von Hoff DD, Soehnlen B: Use of an image analysis system to count colonies in stem cell assays of human tumors. In SE Salmon (ed): Cloning of Human Tumor Stem Cells. A. Liss & Co., New York, 1980, pp 179–193

Powers JF, Sladek NE: Cytotoxic activity relative to 4-hydroxy-cyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats. Cancer Res 43:1101–1106, 1983

Hipkens JH, Struck RF, Gurtoo HL: Role of alehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide. Cancer Res 41:3571–3583, 1981

Brock N: Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC 26271), cyclophosphamide metabolites and plain nitrogen mustard compounds. Cancer Treat Rep 60(4):301–308, 1976

Engle TW, Zon G, and Egan W: 31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine. J Med Chem 25:1347–1357, 1982